These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 38237269)

  • 21. Health Care Personnel Exposure Risk Assessment and Management During a Mpox Outbreak in Chicago, Illinois, 17 May to 8 July 2022.
    Zelencik S; VanDine A; Campos-Bovee M; Goitia K; Cela V; Walblay K; Galanto D; Pacilli M; Kim DY; Black SR
    J Infect Dis; 2024 Mar; 229(Supplement_2):S207-S212. PubMed ID: 38019754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monkeypox (Mpox) outbreak during COVID-19 pandemic-Past and the future.
    Aden D; Zaheer S; Kumar R; Ranga S
    J Med Virol; 2023 Apr; 95(4):e28701. PubMed ID: 36951352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.
    Owens LE; Currie DW; Kramarow EA; Siddique S; Swanson M; Carter RJ; Kriss JL; Boersma PM; Lee FC; Spicknall I; Hurley E; Zlotorzynska M; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(13):342-347. PubMed ID: 36995962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digital contact tracing technologies in epidemics: a rapid review.
    Anglemyer A; Moore TH; Parker L; Chambers T; Grady A; Chiu K; Parry M; Wilczynska M; Flemyng E; Bero L
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013699. PubMed ID: 33502000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mpox among Public Festival Attendees, Chicago, Illinois, USA, July-August 2022.
    Faherty EAG; Teran RA; Black SR; Chundi V; Smith S; Bernhardt B; Weber E; Brassil B; Ruestow P; Kerins JL
    Emerg Infect Dis; 2023 May; 29(5):1059-1061. PubMed ID: 37044128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mpox (Monkeypox) and the Eye: Ocular Manifestation, Diagnosis, Treatment and Vaccination.
    Zong Y; Kamoi K; Zhang J; Yang M; Ohno-Matsui K
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mpox outbreak 2022: an overview of all cases reported to the Cologne Health Department.
    Kröger ST; Lehmann MC; Treutlein M; Fiethe A; Kossow A; Küfer-Weiß A; Nießen J; Grüne B
    Infection; 2023 Oct; 51(5):1369-1381. PubMed ID: 36787016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mpox Person-to-Person Transmission-Where Have We Got So Far? A Systematic Review.
    Pinto P; Costa MA; Gonçalves MFM; Rodrigues AG; Lisboa C
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Household Transmission of Mpox to Children and Adolescents, California, 2022.
    Wendorf KA; Ng R; Stainken C; Haddix M; Peterson E; Watson J; Sachdev D
    J Infect Dis; 2024 Mar; 229(Supplement_2):S203-S206. PubMed ID: 37831784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human monkeypox virus in the shadow of the COVID-19 pandemic.
    Khamees A; Awadi S; Al-Shami K; Alkhoun HA; Al-Eitan SF; Alsheikh AM; Saeed A; Al-Zoubi RM; Zoubi MSA
    J Infect Public Health; 2023 Aug; 16(8):1149-1157. PubMed ID: 37269693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission dynamics and effect of control measures on the 2022 outbreak of mpox among gay, bisexual, and other men who have sex with men in England: a mathematical modelling study.
    Zhang XS; Mandal S; Mohammed H; Turner C; Florence I; Walker J; Niyomsri S; Amirthalingam G; Ramsay M; Charlett A; Vickerman P
    Lancet Infect Dis; 2024 Jan; 24(1):65-74. PubMed ID: 37708908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Pilot of an Mpox Severity Scoring System.
    Zucker J; McLean J; Huang S; DeLaurentis C; Gunaratne S; Stoeckle K; Glesby MJ; Wilkin TJ; Fischer W; Damon I; Brooks JT
    J Infect Dis; 2024 Mar; 229(Supplement_2):S229-S233. PubMed ID: 37956401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic and Clinical Features of Mpox in Transgender and Gender-Diverse Adults - United States, May-November 2022.
    Blackburn D; Roth NM; Gold JAW; Pao LZ; Olansky E; Torrone EA; McClung RP; Ellington SR; Delaney KP; Carnes N; Dawson P
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1605-1609. PubMed ID: 36580418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study.
    Yano R; Terada-Hirashima J; Uemura Y; Tomita N; Shimizu Y; Iwasaki H; Okumura N; Suzuki T; Saito S; Ujiie M; Sugiura W; Ohmagari N
    JMIR Res Protoc; 2023 Aug; 12():e46955. PubMed ID: 37624623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mpox on Reddit: a Thematic Analysis of Online Posts on Mpox on a Social Media Platform among Key Populations.
    Hong C
    J Urban Health; 2023 Dec; 100(6):1264-1273. PubMed ID: 37580545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimated incubation period distributions of mpox using cases from two international European festivals and outbreaks in a club in Berlin, May to June 2022.
    McFarland SE; Marcus U; Hemmers L; Miura F; Iñigo Martínez J; Martínez FM; Montalbán EG; Chazelle E; Mailles A; Silue Y; Hammami N; Lecompte A; Ledent N; Vanden Berghe W; Liesenborghs L; Van den Bossche D; Cleary PR; Wallinga J; Robinson EP; Johansen TB; Bormane A; Melillo T; Seidl C; Coyer L; Boberg R; Jurke A; Werber D; Bartel A
    Euro Surveill; 2023 Jul; 28(27):. PubMed ID: 37410383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data.
    Rosen JB; Arciuolo RJ; Pathela P; Boyer CB; Baumgartner J; Latash J; Malec L; Lee EH; Reddy V; King R; Edward Real J; Lipsitch M; Zucker JR
    Vaccine; 2024 Jan; 42(3):548-555. PubMed ID: 38218669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CDC Domestic Mpox Response - United States, 2022-2023.
    McQuiston JH; Braden CR; Bowen MD; McCollum AM; McDonald R; Carnes N; Carter RJ; Christie A; Doty JB; Ellington S; Fehrenbach SN; Gundlapalli AV; Hutson CL; Kachur RE; Maitland A; Pearson CM; Prejean J; Quilter LAS; Rao AK; Yu Y; Mermin J
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):547-552. PubMed ID: 37200231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Description of the first global outbreak of mpox: an analysis of global surveillance data.
    Laurenson-Schafer H; Sklenovská N; Hoxha A; Kerr SM; Ndumbi P; Fitzner J; Almiron M; de Sousa LA; Briand S; Cenciarelli O; Colombe S; Doherty M; Fall IS; García-Calavaro C; Haussig JM; Kato M; Mahamud AR; Morgan OW; Nabeth P; Naiene JD; Navegantes WA; Ogundiran O; Okot C; Pebody R; Matsui T; Ramírez HL; Smallwood C; Tasigchana RFP; Vaughan AM; Williams GS; ; Mala PO; Lewis RF; Pavlin BI; le Polain de Waroux O
    Lancet Glob Health; 2023 Jul; 11(7):e1012-e1023. PubMed ID: 37349031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study.
    Muller MP; Navarro C; Wilson SE; Shulha HP; Naus M; Lim G; Padhi S; McGeer A; Finkelstein M; Liddy A; Bettinger JA;
    Vaccine; 2024 Jan; 42(3):535-540. PubMed ID: 38199921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.